[{"Assets_0_Q3_USD":83342671.0,"CommonStockSharesOutstanding_0_Q3_shares":156332319.0,"NetIncomeLoss_1_Q3_USD":-2839944.0,"NetIncomeLoss_2_Q3_USD":-7575861.0,"StockholdersEquity_0_Q3_USD":40284955.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]